Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty
Authors:
- 1 February 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 10 (1) , 32-36
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. Effect of adding hormone replacement therapyJoint Bone Spine, 2001
- Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT StudyOsteoporosis International, 1999
- Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention TrialJAMA, 1998
- The Metal-Cancellous Cementless Lübeck total hip arthroplasty. Five-to-nine-year results.The Journal of Bone and Joint Surgery. British volume, 1998
- Cyclical Etidronate in the Treatment of Postmenopausal OsteoporosisThe American Journal of Medicine, 1997
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosisBone, 1996
- Measurement of bone mineral density by dual-energy x-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stemThe Journal of Arthroplasty, 1996
- Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapyThe American Journal of Medicine, 1993
- Cementless prosthesis of the hip joint with ?spongy metal? surfaceArchives of orthopaedic and trauma surgery, 1992